Details of the Drug

General Information of Drug (ID: DMCUNZL)

Drug Name

E2023

Synonyms

Lorcaserin

Indication

Disease Entry	ICD 11	Status	REF
Dravet syndrome	8A61.11	Phase 3	[1]
------------------------------------------------------------------------------------

ATC Code

A08AA11: E2023

A08AA: Centrally acting antiobesity products

A08A: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS

A08: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS

A: ALIMENTARY TRACT AND METABOLISM

Drug Type

Small molecule

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04572243) A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study With Open-Label Extension Phase of Lorcaserin as Adjunctive Treatment in Subjects With Dravet Syndrome. U.S.National Institutes of Health.